Literature DB >> 2769723

Evidence for genetic heterogeneity in tuberous sclerosis.

J R Sampson1, J R Yates, L A Pirrit, P Fleury, I Winship, P Beighton, J M Connor.   

Abstract

The question of genetic heterogeneity in tuberous sclerosis (TSC) was addressed by genetic linkage studies in eight affected families using nine polymorphic markers (EFD126.3, MCT136, ABO, ABL, AK1, and MCOA12 from distal 9q, and PBGD, MCT128.1, and 1CJ52.208M from distal 11q). The data as a whole supported a TSC locus on distal 9q, the peak lod score on multipoint analysis being 3.77 at 6 cM proximal to the Abelson oncogene locus (ABL). However, analysis of two point lod scores using the HOMOG programs showed significant evidence for genetic heterogeneity (p = 0.01), linkage to ABL being unlikely in one family. After exclusion of the unlinked family, multipoint analysis gave a peak lod score of 6.1 in the vicinity of ABL. The family unlinked to ABL showed no recombinants with two chromosome 11 probes, but was too small to provide significant evidence for linkage. Genetic heterogeneity in TSC will complicate efforts to clone the causative genes and severely limit the use of linked probes for carrier detection and prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2769723      PMCID: PMC1015673          DOI: 10.1136/jmg.26.8.511

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  A MspI polymorphism for the human porphobilinogen deaminase gene.

Authors:  D H Llewellyn; N A Kalsheker; G H Elder; P R Harrison; S Chretien; M Goossens
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

2.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  Tuberous sclerosis: analysis of linkage to red cell and plasma protein markers.

Authors:  J M Connor; J R Yates; L Mann; D A Aitken; J B Stephenson
Journal:  Cytogenet Cell Genet       Date:  1987

4.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

5.  Report of the Committee on Methods of Linkage Analysis and Reporting.

Authors:  P M Conneally; J H Edwards; K K Kidd; J M Lalouel; N E Morton; J Ott; R White
Journal:  Cytogenet Cell Genet       Date:  1985

6.  Tuberous sclerosis and ABO.

Authors:  J H Renwick
Journal:  Lancet       Date:  1987-11-07       Impact factor: 79.321

7.  Linkage of tuberous sclerosis to ABO blood group.

Authors:  H Northrup; A L Beaudet; W E O'Brien; G E Herman; R A Lewis; M S Pollack
Journal:  Lancet       Date:  1987-10-03       Impact factor: 79.321

8.  Linkage of the tuberous sclerosis locus to a DNA polymorphism detected by v-abl.

Authors:  J M Connor; L A Pirrit; J R Yates; A E Fryer; M A Ferguson-Smith
Journal:  J Med Genet       Date:  1987-09       Impact factor: 6.318

9.  Linkage analysis and family classification under heterogeneity.

Authors:  J Ott
Journal:  Ann Hum Genet       Date:  1983-10       Impact factor: 1.670

10.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more
  14 in total

1.  Exclusion mapping of the X-linked dominant chondrodysplasia punctata/ichthyosis/cataract/short stature (Happle) syndrome: possible involvement of an unstable pre-mutation.

Authors:  H Traupe; D Müller; D Atherton; D C Kalter; F P Cremers; B A van Oost; H H Ropers
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

2.  Evidence for genetic heterogeneity in tuberous sclerosis: one locus on chromosome 9 and at least one locus elsewhere.

Authors:  H Northrup; D J Kwiatkowski; E S Roach; W B Dobyns; R A Lewis; G E Herman; E Rodriguez; S P Daiger; S H Blanton
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

Review 3.  DNA and classical genetic markers in schizophrenia.

Authors:  M J Owen; P McGuffin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

4.  Genetic heterogeneity in tuberous sclerosis: phenotypic correlations.

Authors:  I M Winship; J M Connor; P H Beighton
Journal:  J Med Genet       Date:  1990-07       Impact factor: 6.318

Review 5.  Genomic imprinting: review and relevance to human diseases.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

Review 6.  New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex.

Authors:  Hilaire C Lam; Julie Nijmeh; Elizabeth P Henske
Journal:  J Pathol       Date:  2016-11-29       Impact factor: 7.996

7.  Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients.

Authors:  K S Au; J A Rodriguez; J L Finch; K A Volcik; E S Roach; M R Delgado; E Rodriguez; H Northrup
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

8.  Identification of a nonsense mutation at the 5' end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis complex.

Authors:  R Vrtel; S Verhoef; K Bouman; M M Maheshwar; M Nellist; A J van Essen; P L Bakker; C J Hermans; M T Bink-Boelkens; R M van Elburg; M Hoff; D Lindhout; J Sampson; D J Halley; A M van den Ouweland
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

9.  A third gene locus for tuberous sclerosis is closely linked to the phenylalanine hydroxylase gene locus.

Authors:  R Fahsold; H D Rott; P Lorenz
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

10.  Tuberous sclerosis and polycystic kidney disease in a 3-month-old infant.

Authors:  Martin W Laass; Miriam Spiegel; Anna Jauch; Gabriele Hahn; Edgar Rupprecht; Christian Vogelberg; Oliver Bartsch; Angela Huebner
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.